The ability to harness technologies like artificial intelligence to change how we research and treat disease could fundamentally transform health. AI has the potential to reshape the patient experience and increase the speed and precision of medicine discovery. GSK is using AI and machine learning at both ends of the R&D spectrum, at the early discovery stage and also in the clinic, using pathology and digital twins to match the right medicine for the right patient. Join to hear how AI and machine learning are helping GSK get ahead of disease.
